Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro

International Journal of Antimicrobial Agents
Ming ChenLeif P Andersen

Abstract

Treatment failures are common in patients infected with metronidazole-resistant Helicobacter pylori in the gastric mucosa when triple therapy including metronidazole is used. In patients with treatment failure and metronidazole-resistant H. pylori, a higher eradication rate for H. pylori was found after secondary treatment with bismuth/ranitidine in combination with antibiotics including metronidazole, compared with the same antibiotics combined with a standard dose of omeprazole. This agrees with our previous finding that bismuth was able to reduce the susceptibility of H. pylori to metronidazole. In this study, we have found that nizatidine, an H(2)-receptor antagonist, is also able to reduce the susceptibility of H. pylori to metronidazole in vitro, despite having no direct inhibitory effect on the growth of H. pylori. This agrees with earlier findings that compounds having the ability to reverse antibiotic resistance do not necessarily have an antibiotic or chemotherapeutic effect in the sense of growth inhibition. Therefore, it was decided to investigate the effect of nizatidine and omeprazole on the oxidative respiratory chain, as it is known that metronidazole is able to inhibit the activity of fumarate reductase of H. p...Continue Reading

References

Aug 1, 1989·Journal of Clinical Microbiology·F MégraudD Q Hoa
Apr 1, 1989·Pharmacology & Toxicology·J E KristiansenL P Andersen
Jan 1, 1989·Scandinavian Journal of Gastroenterology·T U KosunenG Myllylä
Jun 1, 1988·European Journal of Epidemiology·Y GlupczynskiA Burette
Aug 1, 1995·Archives of Biochemistry and Biophysics·G L MendzS Srinivasan
Apr 1, 1995·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·M Buckley, C O'Morain
Oct 23, 1997·Clinical Microbiology Reviews·B E DunnM J Blaser
Oct 24, 1997·The Journal of Antimicrobial Chemotherapy·J E Kristiansen, L Amaral
Jun 23, 1999·FEMS Immunology and Medical Microbiology·M ChenA Kharazmi
Apr 25, 2000·International Journal of Antimicrobial Agents·L P AndersenJ E Kristiansen
Feb 24, 2001·Gastroenterology Clinics of North America·H Cohen

❮ Previous
Next ❯

Citations

Apr 4, 2007·The Journal of Antimicrobial Chemotherapy·Jette E KristiansenHendrik Keyzer
Feb 6, 2003·International Journal of Biological Macromolecules·P ChristakopoulosH Skaltsa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved